InvestSMART

Althea Group Holdings Limited (ASX: AGH) - Announcements

Current share price for AGH : $0.020 0.001 (4.76%)+

ASX company news and announcements for Althea Group Holdings Limited (AGH) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Althea Group Holdings Limited (AGH) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Althea Group Holdings Limited (AGH), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Althea Group Holdings Limited (AGH)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
- Annual Report to Shareholders 27 Aug 2020 11:14AM $0.375 $0.020 fallen by 94.67%
- Online Sales Drive Record Revenue in July 17 Aug 2020 8:17AM $0.350 $0.020 fallen by 94.29%
- Statement Pursuant to Listing Rule 4.7C 14 Aug 2020 5:21PM $0.350 $0.020 fallen by 94.29%
- Appendix 4C - quarterly 16 Jul 2020 8:29AM $0.360 $0.020 fallen by 94.44%
- Althea Launches Online Sales of Medicinal Cannabis Products 8 Jul 2020 8:24AM $0.345 $0.020 fallen by 94.20%
- MyAccess Clinics Enters Drug Science Project Twenty21 24 Jun 2020 8:23AM $0.355 $0.020 fallen by 94.37%
- Peak Signs Production Agreement With Collective Project 22 Jun 2020 8:35AM $0.355 $0.020 fallen by 94.37%
- Response to Appendix 3Y Query 27 May 2020 8:24AM $0.385 $0.020 fallen by 94.81%
- Althea Executes Germany Supply And Distribution Agreement 1 May 2020 8:25AM $0.390 $0.020 fallen by 94.87%
- Appendix 4C - quarterly 15 Apr 2020 8:19AM $0.375 $0.020 fallen by 94.67%
- Final Evidence Package Submitted to Health Canada - Updated 7 Apr 2020 8:27AM $0.290 $0.020 fallen by 93.10%
- Final Evidence Package Submitted to Health Canada 6 Apr 2020 7:18PM $0.290 $0.020 fallen by 93.10%
- Significant Progress Across Australia, UK and Canada 30 Mar 2020 8:27AM $0.210 $0.020 fallen by 90.48%
- Extension of Voluntary Escrow 23 Mar 2020 8:25AM $0.175 $0.020 fallen by 88.57%
- Change of Director's Interest Notice 20 Mar 2020 12:36PM $0.170 $0.020 fallen by 88.24%
- Ceasing to be a substantial holder from PDL 17 Mar 2020 4:21PM $0.185 $0.020 fallen by 89.19%
- Half Yearly Report and Accounts 26 Feb 2020 9:01AM $0.325 $0.020 fallen by 93.85%
- Strong Patient Growth in January 11 Feb 2020 8:25AM $0.375 $0.020 fallen by 94.67%
- Investor Presentation 29 Jan 2020 8:19AM $0.450 $0.020 fallen by 95.56%
- Appendix 4C - quarterly 29 Jan 2020 8:18AM $0.450 $0.020 fallen by 95.56%
- Althea Exceeds 4000 Patients with 48% Month on Month Growth 7 Jan 2020 8:33AM $0.460 $0.020 fallen by 95.65%
- Whistleblower Policy 27 Dec 2019 3:50PM $0.343 $0.020 fallen by 94.16%
- Althea approaching 4,000 patients in Australia 17 Dec 2019 8:24AM $0.345 $0.020 fallen by 94.20%
- Results of Meeting 27 Nov 2019 3:35PM $0.400 $0.020 fallen by 95%
- 2019 AGM CEO Address 27 Nov 2019 1:42PM $0.390 $0.020 fallen by 94.87%

326 - 350 of 486 results

Page 14 of 20

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.